Infantile and congenital hemangiomas

Area of Science:

• Pediatric Vascular Anomalies
• Dermatology
• Neonatal Medicine

Background:

• Infantile hemangiomas (IHs) are the most frequent benign vascular tumors in infants.
• Most IHs involute spontaneously, often without lasting effects, negating the need for treatment.
• Intervention is indicated for specific complications such as ulceration, cosmetic concerns, or functional impairment.

Purpose of the Study:

• To differentiate infantile hemangiomas (IHs) from congenital hemangiomas (CHs).
• To outline the natural history and risk factors associated with IHs.
• To discuss the management strategies for IHs and CHs.

Main Methods:

• Review of clinical findings and natural history of infantile hemangiomas.
• Histological and immunohistochemical comparison of IHs and congenital hemangiomas.
• Analysis of indications for treatment and management approaches for both entities.

Main Results:

• Infantile hemangiomas typically involute without intervention.
• Treatment is reserved for IHs with ulceration, disfigurement, or functional impairment.
• Congenital hemangiomas are distinct from IHs, with unique histological and clinical characteristics.

Conclusions:

• Understanding the natural history of IHs is crucial for appropriate management decisions.
• Congenital hemangiomas represent a separate clinical entity requiring distinct consideration.
• Management should be individualized based on IH characteristics, potential complications, and patient factors.